Drug intelligence / Profile preview

Bao Tai Ling Tablets

Development stage: Unknown
Lead developer: Zhejiang Kangde Pharmaceutical Group
Administration: Oral

Overview

Bao Tai Ling Tablets is a traditional Chinese medicine (TCM) formulation developed and manufactured by Zhejiang Kangde Pharmaceutical. It is primarily indicated for the prevention of miscarriage (threatened abortion) and the treatment of habitual miscarriage. The formulation typically contains a blend of herbal ingredients such as *Cuscuta chinensis*, *Dipsacus asper*, and *Taxillus chinensis*, which are traditionally believed to nourish the kidneys, strengthen the reproductive meridians, and stabilize the fetus. It is administered orally and is approved for use in China.

Brand names: Bao Tai Ling Tablets
Other names: Baotailing PianBaotailing Tablets

Beyond the preview

Go deeper on Bao Tai Ling Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bao Tai Ling Tablets.

Explore the full profile